Corporate News 24-May-17
Orchid Pharma receives ANDA approval for Aripiprazole Tablets
From USFDA
Orchid Pharma has received ANDA approval from USFDA for Aripiprazole Tablets USP, 2 mg, 5 mg, 10 mg, 15 mg, 20 mg and 30 mg.
Previous News
Orchid Pharma hits 52 week high on recording nearly 4x jump in Q3 PAT
( Hot Pursuit - 09-Feb-24 12:58 )
Orchid Pharma AGM scheduled
( Corporate News - 23-Jun-22 17:13 )
Orchid Pharma reports consolidated net loss of Rs 30.90 crore in the June 2021 quarter
( Results - Announcements 14-Aug-21 12:43 )
Orchid Pharma to convene EGM
( Corporate News - 05-Dec-22 09:39 )
Orchid Pharma schedules board meeting
( Corporate News - 05-Nov-20 16:30 )
Orchid Pharma to table results
( Corporate News - 04-May-23 11:36 )
Orchid Chemicals gains on reports of debt rejig plan
( Hot Pursuit - 16-Sep-15 14:40 )
Orchid Pharma Ltd leads gainers in 'B' group
( Hot Pursuit - 09-Feb-24 12:15 )
Orchid Pharma gets 90-days extension for CIRP
( Corporate News - 19-Jan-18 19:03 )
Orchid Pharma to convene board meeting
( Corporate News - 07-Feb-22 10:23 )
Orchid Chemicals & Pharmaceuticals receives Establishment Inspection Report (EIR) from USFDA
( Corporate News - 31-Dec-15 17:45 )
Other Stories
Time Technoplast repays commercial paper
03-Jul-24 18:31
Board of Aditya Vision approves stock split and listing of share on NSE
03-Jul-24 18:24
Pricol director resigns
03-Jul-24 18:21
Board of VMS Industries recommends first interim dividend
03-Jul-24 17:49
Lakshmi Machine Works to declare Quarterly Result
03-Jul-24 17:44
Modison to convene AGM
03-Jul-24 17:43
Sybly Industries to discuss results
03-Jul-24 17:43
Akme Fintrade (India) to announce Quarterly Result
03-Jul-24 17:43
Ponni Sugars (Erode) to hold board meeting
03-Jul-24 17:43
Aditya Vision to conduct AGM
03-Jul-24 17:43
Back
Top
